Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndrome
- 1 November 1997
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 17 (11) , 1011-1018
- https://doi.org/10.1002/(sici)1097-0223(199711)17:11<1011::aid-pd193>3.0.co;2-1
Abstract
Two groups of pregnant women were questioned regarding their opinions on serum screening for Down's syndrome in the first trimester of pregnancy. One group comprised 83 women attending our antenatal clinic who were questioned at the time of the existing second‐trimester screening test. Seventy‐six per cent of those who participated in the second‐trimester screening programme would have preferred the test to have been in the first trimester, mainly because of the easier termination of pregnancy and/or the earlier reassurance provided. The remaining 24 per cent could see no advantage in the earlier time frame. Of the 49 women who had declined second‐trimester screening, only two would have participated in screening had it been in the first trimester. The other group comprised those women attending our antenatal diagnosis clinic who were considering chorionic villus sampling (CVS). Forty‐four per cent of these women would have allowed serum screening in the first trimester to influence their decision as to whether to undergo definitive prenatal diagnostic testing. In general, those women who made use of second‐trimester serum screening would also do so in the first trimester. Those who declined the existing screening programme would also decline first‐trimester screening. Many women currently deciding to undergo CVS would allow a first‐trimester screening test to influence their decision. © 1997 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Chorionic villus sampling safety Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel-Aviv, Israel, May 21, 1994American Journal of Obstetrics and Gynecology, 1996
- Abortion mortality, United States, 1972 through 1987American Journal of Obstetrics and Gynecology, 1994
- Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for ScreeningNew England Journal of Medicine, 1994
- Anxiety in women with low maternal serum alpha‐fetoprotein screening resultsPrenatal Diagnosis, 1991
- Severe limb abnormalities after chorion villus sampling at 56-66 days' gestationThe Lancet, 1991
- Low level of maternal serum α-fetoprotein: Its associated anxiety and the effects of genetic counselingAmerican Journal of Obstetrics and Gynecology, 1991
- The predictive value of cytogenetic diagnosis after CVS: 1500 casesPrenatal Diagnosis, 1990
- 5 The loss of early pregnancyBailliere's Clinical Obstetrics and Gynaecology, 1989
- Determinants of altered anxiety after abnormal maternal serum α-fetoprotein screeningAmerican Journal of Obstetrics and Gynecology, 1988
- Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortionsTeratology, 1975